These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1127 related items for PubMed ID: 16634900

  • 21. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
    Khanfar N, Loudon D, Sircar-Ramsewak F.
    Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
    [Abstract] [Full Text] [Related]

  • 22. Drug advertisements in two dermatology journals: a critical comparison of IJDVL and JAAD.
    Gahalaut P, Chauhan S, Mishra N, Rastogi M, Thakur R.
    Indian J Dermatol Venereol Leprol; 2014; 80(2):115-21. PubMed ID: 24685846
    [Abstract] [Full Text] [Related]

  • 23. Mixed messages on tobacco: comparative exposure to public health, tobacco company- and pharmaceutical company-sponsored tobacco-related television campaigns in the United States, 1999-2003.
    Wakefield M, Szczypka G, Terry-McElrath Y, Emery S, Flay B, Chaloupka F, Saffer H.
    Addiction; 2005 Dec; 100(12):1875-83. PubMed ID: 16367989
    [Abstract] [Full Text] [Related]

  • 24. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.
    Lexchin J, Holbrook A.
    CMAJ; 1994 Jul 01; 151(1):47-54. PubMed ID: 8004560
    [Abstract] [Full Text] [Related]

  • 25. Consumer advertising of psychiatric medications biases the public against nonpharmacological treatment.
    Lacasse JR.
    Ethical Hum Psychol Psychiatry; 2005 Jul 01; 7(3):175-9. PubMed ID: 16604742
    [Abstract] [Full Text] [Related]

  • 26. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA.
    Issue Brief Health Policy Track Serv; 2009 Jan 05; ():1-28. PubMed ID: 19297718
    [No Abstract] [Full Text] [Related]

  • 27. Dermatology Internet Yellow Page advertising.
    Francis S, Kozak KZ, Heilig L, Lundahl K, Bowland T, Hester E, Best A, Dellavalle RP.
    J Am Acad Dermatol; 2006 Jul 05; 55(1):67-70. PubMed ID: 16781294
    [Abstract] [Full Text] [Related]

  • 28. Which prescription for the illegible and unreadable DTC (direct-to-consumer) brief summary--major surgery or euthanasia?
    Hochhauser M.
    Manag Care Q; 2002 Jul 05; 10(3):6-10. PubMed ID: 12476659
    [Abstract] [Full Text] [Related]

  • 29. Medical Marketing in the United States, 1997-2016.
    Schwartz LM, Woloshin S.
    JAMA; 2019 Jan 01; 321(1):80-96. PubMed ID: 30620375
    [Abstract] [Full Text] [Related]

  • 30. Regulating pharmaceutical advertising: what will work?
    Shapiro MF.
    CMAJ; 1997 Feb 01; 156(3):359-61. PubMed ID: 9033416
    [Abstract] [Full Text] [Related]

  • 31. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship.
    Robinson AR, Hohmann KB, Rifkin JI, Topp D, Gilroy CM, Pickard JA, Anderson RJ.
    Arch Intern Med; 2004 Feb 23; 164(4):427-32. PubMed ID: 14980994
    [Abstract] [Full Text] [Related]

  • 32. FDA considers tightening regulations for direct-to-consumer advertising.
    Vastag B.
    J Natl Cancer Inst; 2005 Dec 21; 97(24):1806-7. PubMed ID: 16368941
    [No Abstract] [Full Text] [Related]

  • 33. Capitol Hill panelists want FDA intervention in DTC drug advertising.
    Med Health; 2005 Oct 10; 59(36):1, 6, 8. PubMed ID: 16238177
    [No Abstract] [Full Text] [Related]

  • 34. Examining the FDA's oversight of direct-to-consumer advertising.
    Gahart MT, Duhamel LM, Dievler A, Price R.
    Health Aff (Millwood); 2003 Oct 10; Suppl Web Exclusives():W3-120-3. PubMed ID: 14527243
    [Abstract] [Full Text] [Related]

  • 35. FDA tightens rules on advertising.
    Josefson D.
    BMJ; 1997 Aug 23; 315(7106):447. PubMed ID: 9284658
    [No Abstract] [Full Text] [Related]

  • 36. Direct-to-consumer advertising of prescription medications: implications for patients with cancer.
    Viale PH.
    Oncol Nurs Forum; 2002 Apr 23; 29(3):505-13. PubMed ID: 11979283
    [Abstract] [Full Text] [Related]

  • 37. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW, Bang HK.
    Health Mark Q; 2000 Apr 23; 17(3):39-56. PubMed ID: 11010219
    [Abstract] [Full Text] [Related]

  • 38. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J.
    Food Drug Law J; 2003 Apr 23; 58(4):629-48. PubMed ID: 15027454
    [No Abstract] [Full Text] [Related]

  • 39. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
    Berndt ER.
    N Engl J Med; 2005 Jan 27; 352(4):325-8. PubMed ID: 15673797
    [No Abstract] [Full Text] [Related]

  • 40. Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
    Huh J, Cude BJ.
    J Health Commun; 2004 Jan 27; 9(6):529-40. PubMed ID: 15764451
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.